Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H12N2O2S |
Molecular Weight | 248.301 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
InChI
InChIKey=MQJKPEGWNLWLTK-UHFFFAOYSA-N
InChI=1S/C12H12N2O2S/c13-9-1-5-11(6-2-9)17(15,16)12-7-3-10(14)4-8-12/h1-8H,13-14H2
Molecular Formula | C12H12N2O2S |
Molecular Weight | 248.301 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:04:08 UTC 2023
by
admin
on
Sat Dec 16 16:04:08 UTC 2023
|
Record UNII |
8W5C518302
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000008053
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
||
|
NCI_THESAURUS |
C849
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
||
|
WHO-VATC |
QD10AX05
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.3
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
||
|
WHO-ATC |
J04BA02
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
||
|
WHO-VATC |
QJ04BA02
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
||
|
WHO-ATC |
D10AX05
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
||
|
FDA ORPHAN DRUG |
85694
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
||
|
NDF-RT |
N0000175881
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
||
|
NDF-RT |
N0000008053
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
||
|
FDA ORPHAN DRUG |
61291
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
||
|
EPA PESTICIDE CODE |
690107
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
||
|
LIVERTOX |
NBK548936
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
||
|
FDA ORPHAN DRUG |
61191
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
8W5C518302
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
5073
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
D003622
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
2955
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
SUB06909MIG
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
CHEMBL1043
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
8W5C518302
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
80-08-0
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
3108
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | RxNorm | ||
|
782
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
201-248-4
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
m4092
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000083461
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
1164008
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
4325
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
1676
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
DAPSONE
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | Description: A white or creamy white, crystalline powder; odourless. Solubility: Soluble in 7000 parts of water and in 30 parts of ethanol (~750 g/l) TS; soluble in acetone R.Category: Antileprotic. Storage: Dapsone should be kept in a tightly closed container, protected from light. Additional information: Even in the absence of light, Dapsone is gradually degraded on exposure to a humid atmosphere, thedecomposition being faster at higher temperatures. | ||
|
DAPSONE
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
Dapsone
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
DB00250
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
6091
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
C415
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY | |||
|
DTXSID4020371
Created by
admin on Sat Dec 16 16:04:10 UTC 2023 , Edited by admin on Sat Dec 16 16:04:10 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
PARENT -> METABOLITE |
We have also shown recently that greater than 90% of dapsone hydroxylation in human liver microsomes is undertaken by cytochrome P4503A4
URINE
|
||
|
METABOLITE -> PARENT |
PLASMA
|
||
|
METABOLITE TOXIC -> PARENT |
Metabolite known for methaemoglobin formation in man.
|
||
|
METABOLITE -> PARENT |
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|